Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04178694
Other study ID # B.U.N. 143201940980
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date May 13, 2020

Study information

Verified date April 2020
Source Universitair Ziekenhuis Brussel
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Before inclusion in the trial. Careful medical history and medication use will be asked. Once included, 5 healthy subjects non-invasive ventilation(V60, Philips, Eindhoven, The Netherlands) will be administered at a level of positive end expiratory pressure (PEEP) of 4 cmH2O and without additional inspiratory support. Inspiratory support will then increase by 2 cmH2O every 2 minutes until 8 cmH2O is achieved for 2 minutes. The energy expenditure is measured using indirect calorimetry (Q-NRG®, Cosmed, Italy). To measure respiratory effort, the reversed RPE-scale was created for the purpose of the study. It uses the validated "rate of perceived exertion" scale (RPE-scale) which was altered by adding a reversed part. This could result in a score of -10 (no respiratory effort) until +10 ( maximal respiratory effort) where 0 represents the basal respiratory condition. Monitoring of heart rate, blood pressure and cardiac output will be done ( Nexfin®, BMEYE, Amsterdam, The Netherlands).

After termination of the study clinical observation by principal investigator or co-investigator will be done for 15 minutes or until all side effects have worn off. If no side effects are observed, subjects will be released.


Recruitment information / eligibility

Status Completed
Enrollment 5
Est. completion date May 13, 2020
Est. primary completion date May 13, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- healthy volunteers

Exclusion Criteria:

- pregnancy

- prisoners

- participation in interventional study in last 2 weeks before enrolment

- Current ongoing disease:

- Cardiac

- respiratory

- ear

- nose

- gastro-intestinal

- neurological

- psychiatric

Study Design


Related Conditions & MeSH terms


Intervention

Device:
non-invasive ventilation
non-invasive ventilation will be performed on every subjects

Locations

Country Name City State
Belgium Universitair ziekenhuis Brussel Jette Brussel

Sponsors (1)

Lead Sponsor Collaborator
Universitair Ziekenhuis Brussel

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Energy expenditure in kcal/day Energy expenditure will be measured using indirect calorimetry during different settings of non invasive ventilation during non-invasive ventilation
Secondary reversed combined rate of perceived exertion scale no unit, range: [-10 , +10] based on an existing scale of perceived exertion, a reverse part was added to be able to measure an improvement of respiratory exercise compared to normal state. during non-invasive ventilation
Secondary respiratory rate in breaths/min during non-invasive ventilation
Secondary systolic and diastolic bloodpressure in mmHg during non-invasive ventilation
Secondary cardiac output in liter/min during non-invasive ventilation
Secondary CO2 production of the body ( VCO2) in ml/min during non-invasive ventilation
Secondary O2 consumption of the body (VO2) in ml/min during non-invasive ventilation
Secondary Respiratory quotient no unit during non-invasive ventilation
See also
  Status Clinical Trial Phase
Completed NCT00070577 - Influence of Age and Sex on Alcohol Metabolism and Acute Responses N/A
Active, not recruiting NCT05488574 - Effects of Novel Breathing Behavior Modification Yoga Positioning Integrated Program on Weight Loss N/A
Recruiting NCT05582824 - Lactate Metabolism in the Hypoperfused Critically Ill
Recruiting NCT05443347 - Activity, Adiposity, and Appetite in Adolescents 2 Intervention N/A
Completed NCT05020808 - The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise N/A
Recruiting NCT06082726 - The Systemic Concentration of Short-Chain Fatty Acids After Delivery in the Small and Large Intestine of Healthy Volunteers N/A
Completed NCT04144426 - Meal Schedule Effects on Circadian Energy Balance in Adults N/A
Completed NCT03424395 - Personalized Dietary Program and Markers of Wellness N/A
Completed NCT02441296 - Carbohydrate and Metabolism: a Pilot Study N/A
Completed NCT00176085 - Pharmacokinetics of THCCOOH and Its Acyl-glucuronide After Intravenous Administration of THCCOOH Phase 1
Completed NCT00245986 - Effect of Genetics on Metabolism of Efavirenz Phase 4
Completed NCT04025346 - To Evaluate the Efficacy of Capsimax on Metabolic Rate N/A
Completed NCT04078646 - Influence of Proteins on the Bioavailability of Carotenoids N/A
Active, not recruiting NCT06033898 - Inactivity Duration on Lipid Metabolism N/A
Active, not recruiting NCT06250270 - Effects of Casein Protein on Metabolism When Taken Prior to Sleep and in the Morning Early Phase 1
Completed NCT06285578 - Effects of Probiotic and HIIT in Obese Women N/A
Completed NCT04255368 - Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response N/A
Recruiting NCT06360796 - Study of Pharmacokinetics and Metabolism on [(14)C]ADC189 Phase 1
Recruiting NCT02005003 - Cognitive and Metabolic Effects of a Probiotic Supplement N/A
Completed NCT03146728 - Finding the Optimal Voluntary Exercise Parameters for Those Living With Quadriplegia N/A